Wolf-Parkinson-White Syndrome and Asymptomatic Pre-excitation in Africa (a Multicenter WPW African Registry)

Launched by AIN SHAMS UNIVERSITY · Feb 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a heart condition called Wolf-Parkinson-White (WPW) syndrome, which can cause abnormal heart rhythms. The goal is to better understand how patients with WPW syndrome are treated across various African countries, including both those who have symptoms and those who do not. The researchers want to gather information about the health history, symptoms, and management of these patients to improve care for people with this condition.

To participate in the study, individuals must have a specific pattern on their heart test (ECG) that indicates WPW syndrome. Eligible participants include adults of all ages and backgrounds who are visiting heart health clinics or undergoing special heart tests. Those who join the study will have their health history documented, undergo an ECG to confirm their condition, and may provide additional information about their symptoms and family history. It's important to note that participants must agree to take part in the study, and those with certain other heart conditions or devices will not be included. This research aims to help doctors understand WPW syndrome better and enhance treatment for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who have a preexcitation (WPW) pattern on an ECG.
• Exclusion Criteria:
• • any participant who does not consent to the study. Any participants who have structural heart disease History of other arrhythmogenic diseases like Brugada syndrome, Arrhythmogenic AR dysplasia, long QT syndrome..etc Any implantable cardiac rhythm devices